Enantioselective Enzyme-Catalyzed Aziridination Enabled by Active-Site Evolution of a Cytochrome P450 by Farwell, Christopher C. et al.
Enantioselective Enzyme-Catalyzed Aziridination Enabled by Active-
Site Evolution of a Cytochrome P450
Christopher C. Farwell,† Ruijie K. Zhang,† John A. McIntosh, Todd K. Hyster, and Frances H. Arnold*
Division of Chemistry and Chemical Engineering 210-41, California Institute of Technology, 1200 East California Boulevard,
Pasadena, California 91125, United States
*S Supporting Information
ABSTRACT: One of the greatest challenges in protein design is creating
new enzymes, something evolution does all the time, starting from
existing ones. Borrowing from nature’s evolutionary strategy, we have
engineered a bacterial cytochrome P450 to catalyze highly enantiose-
lective intermolecular aziridination, a synthetically useful reaction that has
no natural biological counterpart. The new enzyme is fully genetically
encoded, functions in vitro or in whole cells, and can be optimized rapidly
to exhibit high enantioselectivity (up to 99% ee) and productivity (up to
1,000 catalytic turnovers) for intermolecular aziridination, demonstrated
here with tosyl azide and substituted styrenes. This new aziridination
activity highlights the remarkable ability of a natural enzyme to adapt and
take on new functions. Once discovered in an evolvable enzyme, this non-natural activity was improved and its selectivity tuned
through an evolutionary process of accumulating beneﬁcial mutations.
■ INTRODUCTION
The impressive catalytic diversity of enzymes illustrates the
breadth of reaction space explored throughout biological
evolution. Chemists are taking advantage of this vast repository
of biocatalysts for chemical synthesis; they are also mimicking
nature’s engineering strategy of mutation and selection to
optimize enzyme function for a myriad of applications.1 A
remaining challenge is to create new enzymes for the many
useful reactions that are not known in the biological world. We
and others have argued that learning from nature’s mechanisms
for catalytic innovationexploiting enzyme catalytic promis-
cuity and retaining key elements of structure and mechanism
while exploring new functionscan help us discover new
biocatalysts starting from nature’s vast repertoire.2 The
discovery and optimization of enzyme catalysts for non-natural
reactions has provided alternative routes to important
molecules that would otherwise be unattainable through
biocatalysis.3
Our group4 and that of Fasan5 recently reported that heme
proteins can form reactive metal−nitrenoid species and catalyze
intramolecular C−H amination. We extended this novel
biocatalytic activation mode to intermolecular sulﬁmidation
and showed that the enzyme, derived from a cytochrome P450,
could be tuned by mutation to catalyze nitrene transfer to
various aryl sulﬁdes with good activity and moderate
enantioselectivity (Scheme 1A).6 Because heme proteins do
not encounter nitrene precursors in their natural environments,
they never had the chance to explore and evolve this capability.
But the cytochrome P450’s versatile catalytic framework is
clearly capable of catalytic activities well beyond what nature
has explored.
The extensive literature on reactions catalyzed by metal-
loporphyrins provides inspiration for reactivities that should be
investigated.7−10 Among the nitrene transfer reactions used in
synthetic chemistry, aziridination with azide nitrene sources is
particularly attractive (Scheme 1B), given its high atom
economy and the utility of the aziridine functional group in
chemical synthesis.8 Metalloporphyrin-catalyzed aziridination of
oleﬁns with iminoiodinanes or haloamines as the nitrene source
dates to the 1980s or early 2000s, respectively.9 Advances in the
past ten years have expanded metalloporphyrin-catalyzed
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Scheme 1. Enzyme-Catalyzed Intermolecular Nitrogen Atom
Transfer
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aziridination to include systems that use azide-based nitrene
sources.10
In contrast, enzymes that use electrophilic nitrogen species
are extremely rare (e.g., proposed mechanism of TxtE-catalyzed
nitration of tryptophan11). As a result, natural aziridination
follows an entirely diﬀerent strategy from the metalloporphyrin-
catalyzed aziridination of oleﬁns described above. Indeed, the
biosynthesis of naturally occurring aziridine rings is believed to
proceed by intramolecular nucleophilic displacement.12 Enzyme
catalysts for the convergent synthesis of aziridines from oleﬁns
and azide nitrene precursors would be highly attractive and
would ﬁll a signiﬁcant gap in nature’s biosynthetic repertoire.
During our previous work on sulﬁde imidation catalyzed by
variants of cytochrome P450BM3, two factors appeared to aﬀect
reactivity. First, the reaction was promoted by electron-rich
sulﬁdes, and second, enzyme-catalyzed azide reduction to
sulfonamide represented a signiﬁcant side reaction, particularly
with less reactive, electron-deﬁcient sulﬁdes (Scheme 1).6
Increasing the sulﬁde substrate loading improved the ratio of
sulﬁmide to sulfonamide side product, which suggested to us
that increasing the eﬀective concentration of sulﬁde nitrene
acceptor in the enzyme active site might improve sulﬁmidation
productivity. Given the less reactive nature of oleﬁns relative to
sulﬁdes along with operational limitations to increasing oleﬁn
eﬀective concentration (i.e., their limited solubility in aqueous
media), we surmised that intermolecular aziridination would be
an even more challenging activation mode for the enzyme. We
hypothesized, however, that protein engineering would allow us
to circumvent these limitations if the enzyme could more
eﬀectively bind and orient the substrates in the enzyme active
site for productive nitrene transfer or, alternatively, catalyze the
competing azide reduction less eﬃciently. Here we demonstrate
that active-site engineering can indeed enable a heme protein to
catalyze eﬃcient, highly enantioselective intermolecular nitrene
transfer to oleﬁns to make aziridines.
■ RESULTS AND DISCUSSION
We started this investigation of enzyme-catalyzed aziridination
with an engineered variant of cytochrome P450BM3, P411BM3-
CIS-T438S, previously found to be eﬀective for intramolecular
C−H amination and sulﬁde imidation (see Table S1 for
mutations from wild-type P450BM3).
4,6 We call this enzyme a
“P411” due to the change in the characteristic CO-bound Soret
peak from 450 to 411 nm eﬀected by mutation of the cysteine
residue that coordinates the heme iron to serine (C400S).4,13
This axial cysteine is completely conserved in cytochrome
P450s and is required for the native monooxygenase activity.14
Thus, the P411 enzyme is no longer a “cytochrome P450”, nor
does it exhibit its native hydroxylation activity.13b,15 However,
the C400S mutation increases the non-natural carbene and
nitrene transfer activities of P450BM3
4,6,13 and other P450s.16
Two crystal structures of P411 variants of P450BM3 show that
S400 coordinates the iron and causes no signiﬁcant structural
perturbation in the substrate binding pocket.13
Previous work on enzymatic sulﬁmidation suggested that
electron-rich sulﬁdes promote nitrene transfer.6 Reasoning that
the electronic properties of the oleﬁn substrate could inﬂuence
aziridination as well, we tested the activity of P411BM3-CIS-
T438S toward the electron-rich 4-methoxystyrene using tosyl
azide (TsN3) as the nitrene precursor (Table 1). Tosyl azide
was completely consumed in this reaction, the major product of
which was the azide reduction product p-toluenesulfonamide
(>300 total turnovers (TTN), not shown in Table 1). Amido-
alcohol 2 appeared as a minor product. Control experiments
showed that the desired aziridine product rapidly decomposes
under aqueous reaction conditions to the corresponding amido-
alcohol 2 (Figure S1). Degradation of this aziridine product has
also been observed in studies with small-molecule catalysts.17
We therefore inferred that production of 2 is directly related to
the nitrene transfer activity of the enzyme toward oleﬁn 1.
This low level of nitrene transfer activity to 4-methoxystyrene
of the P411BM3-CIS-T438S enzyme prompted us to investigate
other variants. We chose a small set of cytochrome P450BM3
variants and heme proteins prepared for other studies in order
to assess how changes in the protein sequence aﬀect nitrene
transfer to oleﬁn substrates (Tables S2 and S3). P450BM3
sequences lacking the C400S and/or T268A mutations were
not active, nor did the Fe(II)-protoporphyrin IX (PPIX)
cofactor catalyze aziridination under these conditions. Mutants
diﬀering from P411BM3-CIS-T438S by 2−5 alanine mutations
in the active site showed some aziridination activity (4−8
TTN), but none was more productive than P411BM3-CIS-
T438S. We also tested a set of enzymes containing diﬀerent
axial mutations, including the S400H, S400D, and S400 M
mutants of P411BM3-CIS-T438S. These enzymes were also only
weakly active, giving 2 at levels lower than P411BM3-CIS-T438S
(3−4 TTN). Myoglobin (horse heart), cytochrome c (bovine
heart), and cytochrome P450Rhf (from Rhodococcus sp. NCIMB
9784) were all inactive for this intermolecular aziridination
(Table S3). An engineered variant of the thermostable
cytochrome P450 from Sulfolobus acidocaldarius, CYP119,
that contained an axial cysteine-to-serine mutation (C317S)
did catalyze low levels of aziridination (∼7 TTN). This
demonstrates that mutations previously described to activate
non-natural nitrene-transfer activity in P450BM3 may confer
measurable activity on other P450s as well. In turn, these
enzymes should be suitable starting points for further
engineering.16
Of all the enzymes tested, a variant of P411BM3-CIS-T438S
having a single active-site substitution, I263F, was the most
active toward 4-methoxystyrene by a wide margin, providing
150 total turnovers in the formation of amido-alcohol 2 from 4-
methoxystyrene (Table 1). This variant, which was found to
promote regioselective intramolecular C−H amination in a
previous study,13a supported aziridination at 10-fold increased
Table 1. Total Turnovers (TTN) to Product for
Aziridination Catalyzed by Puriﬁed Holoenzymes P411BM3-
CIS-T438S (P) and P411BM3-CIS-T438S-I263F (P-I263F)
with Selected Styrenyl Oleﬁns 1, 3, and 5 and Tosyl Azidea
TTNb
enzyme 2 4 6
P411BM3-CIS-T438S (P) 15 8 5
P-I263F 150 160 190
aReactions were performed in 0.1 M KPi buﬀer pH = 8.0 using 0.2
mol % enzyme and NADPH as reductant, with 2.5 mM tosyl azide and
7.5 mM oleﬁn. Detailed reaction conditions can be found in the
Supporting Information. bTTN = total turnover number. TTNs were
determined by HPLC analysis.
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total turnovers compared to the P411BM3-CIS-T438S parent
enzyme (henceforth referred to as the P enzyme). Comparison
of these two enzymes’ activities with a set of styrenyl oleﬁns
showed that the P-I263F variant was also more productive with
the less electron-rich 4-methylstyrene (3) and styrene (5)
substrates. Furthermore, P-I263F is more productive with
styrene (5) than with 4-methoxystyrene (1). This trend in
substrate preference is inverted compared to that of the parent
enzyme (Table 1) and the previously observed trend for
intermolecular imidation of sulﬁdes.6 Unlike the aziridine
product that leads to amido-alcohol 2, aziridine products 4 and
6 were stable under the reaction conditions, although some
amido-alcohol product was detected when standards and
samples were analyzed by LC−MS (Figure S2).
P-I263F was even more productive when the reactions were
carried out using whole Escherichia coli cells expressing this
enzyme (Figure S3), consistent with our previous observations
that enzyme-catalyzed metal−nitrenoid and metal−carbenoid
transfer activities improved when the reactions were performed
with whole cells.4,13b (No aziridine product was observed when
cells not expressing the P411 catalyst were used, although tosyl
azide was converted to sulfonamide 7 over the course of the
reaction (Table 2), as reported previously for intramolecular
C−H amination.4) The P-I263F enzyme provided enough
aziridine product in whole-cell reactions to allow for screening
variants in 96-well plate format. Thus, we sought further
improvement by mutagenesis and screening for aziridination
productivity. Site-saturation mutagenesis (SSM) libraries were
created at several active site positions that were previously
shown to inﬂuence productivity and enantioselectivity in other
non-natural reactions (A78, L181, T438, A328).3a,13a Screening
of these single SSM libraries for aziridination of 4-
methylstyrene (3) identiﬁed P-I263F-A328V, with slightly
improved yield and substantially improved % ee (96% ee;
entry 4, Table 2). Another round of SSM performed on this
variant at additional active site positions (F87, T268, L437)
resulted in P-I263F-A328V-L437V with improved aziridine
yield and a further increase in enantioselectivity (99% ee (S)).
The P-I263F-L437V and P-I263F-A328V mutants were both
less selective than P-I263F-A328V-L437V, demonstrating that
both new mutations contribute to the very high enantiose-
lectivity. Importantly, the yield of sulfonamide side product 7
diminished over the course of active site evolution, to the
extent that aziridine 4 became the major product of the reaction
catalyzed by P-I263F-A328V-L437V.
Because the azide is fully consumed in these reactions, the
improved aziridine yield could result from either an increase in
the rate of aziridine formation or a decrease in the rate of
competing azide reduction, or from a combination of both. To
address this, we measured initial rates of reaction with the P-
I263F, P-I263F-A328V, and P-I263F-A328V-L437V enzymes as
puriﬁed holoenzymes (Table S4, Figure S4). Initial rates of
aziridination for the puriﬁed enzymes reﬂected the yield
improvements observed in whole cells: P-I263F and P-I263F-
A328V have similar turnover frequencies (15−16 min−1), while
P-I263F-A328V-L437V, having both new mutations, was
improved (TOF ∼ 24 min−1). The initial turnover frequency
of sulfonamide formation in vitro was similar for all the
enzymes, and faster than aziridine formation (TOFs ∼ 26−29
min−1).
Having obtained a variant capable of high productivity and
enantioselectivity for the aziridination of 4-methylstyrene (3),
we next investigated whole-cell reactions with diﬀerent
substituted styrene substrates (Table 3). In contrast to
enzyme-catalyzed imidation of sulﬁdes,6 we saw no correlation
between the electronics of the aryl substituent and productivity.
In general, the evolved enzyme was more productive with
styrenes substituted at the 4-position, though the highest
productivity was observed with styrene itself. The evolved
enzyme provided 600 catalytic turnovers for the formation of
aziridine 6, corresponding to a 70% yield of 6 (entry 3 in Table
3). With higher styrene and tosyl azide loading, the enzyme
catalyzed 1,000 turnovers for aziridination, while retaining high
(S)-selectivity (99% ee) (Figure S5). Both 3-methylstyrene and
3-chlorostyrene were signiﬁcantly less reactive than their 4-
substituted counterparts, giving 85 and 21 turnovers,
respectively, compared to 450 and 290 turnovers (entries 2,
4, 5, 6 in Table 3). The evolved enzyme is an exceptionally
enantioselective aziridination catalyst with styrene entries 2−4
(Table 3), giving 99% ee in favor of the (S)-enantiomer with
these three substrates. Both 4-methoxystyrene and α-methyl-
styrene (entries 1 and 8 in Table 3) gave exclusively racemic
amido-alcohol product. Formation of the amido-alcohol
product from these substrates may result from carbocation
stabilization at the benzylic position due to the resonance and
hyperconjugative stabilization provided by the respective p-
OMe and α-Me groups, leading to decomposition of the
aziridine product and subsequent carbocation quenching with
water.
The highly enantioselective P-I263F-A328V-L437V variant
has three mutations in its active site relative to the P enzyme
used in initial reaction characterization (P411BM3-CIS-T438S).
The crystal structure of the heme domain of P-I263F was
recently solved and shows how the F263 side chain is oriented
toward the heme cofactor within the active site (PDB ID:
4WG2, Figure S6).13a The eﬀect of the I263F mutation on the
active site is signiﬁcant: the F263 side chain ﬁlls space above the
heme cofactor whereas the I263 side chain is pointed up and
away from the heme (Figure S6). Given the more conservative
nature of the A328V and L437V mutations, these residues likely
Table 2. Improvement in Yield and % ee for Aziridine
Product 4 with Active-Site Evolution of P411BM3-CIS-T438S
(P)a
% yield
entry enzyme 4 7 % ee of 4b
1 no enzymec 0 95 nd
2 P411BM3-CIS-T438S 1.1 95 25
3 P-I263F 40 54 55
4 P-I263F-A328V 43 50 96
5 P-I263F-L437V 37 52 95
6 P-I263F-A328V-L437V 55 43 99
aReactions were carried out using whole E. coli cells resuspended in
M9-N reaction buﬀer under anaerobic conditions, with 2.5 mM tosyl
azide and 7.5 mM 4-methylstyrene. Yield is based on tosyl azide. See
Supporting Information methods for detailed reaction setup and
quantiﬁcation procedures. b% ee determined by SFC analysis and
calculated as (S − R)/(S + R). c“No enzyme” reactions were carried
out using whole cells with no P411 enzyme expressed, as described in
the Supporting Information methods.
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exert more subtle inﬂuences on active site structure, yet their
impact on enantioselectivity is substantial (55% ee with P-
I263F vs 99% ee with P-I263F-A328V-L437V, using 4-
methylstyrene, Table 2).
Beyond I263F, several other mutations in the distal heme
environment are necessary for high aziridination activity. In
particular, reversion of either T268A or F87V in P-I263F
markedly reduces aziridination productivity (Table S2) and
demonstrates some nonadditivity among the activating
mutations (i.e., I263F is activating only in the context of
T268A). Moreover, although previous work has highlighted the
importance of modulating heme electronic properties to access
non-natural reactivity,4,13 here we observe that strong gains in
aziridination activity are brought about by mutations on the
distal heme side, suggesting that their eﬀect may be the result of
improving substrate binding and orientation, a hallmark of
enzyme catalysis that is notable for a new-to-nature reaction
such as P450-catalyzed nitrene transfer.
We propose that aziridine formation begins with reduction of
the iron(III) heme from gaining an electron from NADPH via
the P450BM3 reductase domain, analogous to the mechanism we
proposed for enzyme-catalyzed sulﬁmidation.6 (Control experi-
ments show that NADPH is not capable of reducing P-I263F in
the absence of the reductase domain (Figure S7).) Reaction of
tosyl azide with ferrous heme results in the formation of an iron
nitrenoid species in the active site (formally in the +4 oxidation
state), which can be either intercepted by oleﬁn to produce
aziridine or reduced by a second electron transfer from the
reductase to form an unreactive iron(III) sulfonamide complex.
In the event that sulfonamide is formed, the iron(III) heme
must then consume another reducing equivalent to return to
the reactive ferrous state. Given the key role of the reductase in
catalyzing azide reduction, it should also be possible to improve
aziridine yields by decreasing the rate of electron transfer,
thereby selectively slowing the rate of azide reduction. Electron
transfer in P450BM3 is well studied, and several amino acids
have been identiﬁed to aﬀect this process.18 We are currently
exploring this additional route to enhancing the productivity of
enzyme-catalyzed nitrene transfer reactions.
■ CONCLUSIONS
We report the ﬁrst example of enzyme-catalyzed oleﬁn
aziridination. This challenging intermolecular reaction is
catalyzed by a serine-ligated “P411” variant of cytochrome
P450BM3. That the iron-heme cofactor has no measurable
activity highlights the critical role of the protein in promoting
this activity. Mutations in the enzyme active site resulted in a
variant that exhibits signiﬁcantly improved azide utilization
compared to the parental enzyme and high (S)-selectivity (up
to 99% ee). These results demonstrate the critical role of
protein engineering in optimizing non-natural reactivity and
suggest that the well-known plasticity of the P450 active site
can be leveraged to target progressively more challenging non-
natural reactions.
This new aziridination biocatalyst is likely just one of many
new catalysts that will be discovered when researchers start
systematically exploring the new functions that existing
enzymes can take on.2 Exploiting the catalytic promiscuity of
natural enzymes combined with evolutionary optimization will
enable us to greatly expand the reaction space of genetically
encoded biocatalysts.
■ ASSOCIATED CONTENT
*S Supporting Information
The following ﬁle is available free of charge on the ACS
Publications website at DOI: 10.1021/acscentsci.5b00056.
Figures S1−S19, Tables S1−S4, and experimental
procedures (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: frances@cheme.caltech.edu.
Author Contributions
†C.C.F. and R.K.Z.: equal contribution.
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
We thank Dr. S. Virgil and the 3CS Catalysis Center at Caltech
for assistance with HPLC, chiral HPLC, and LC−MS analysis.
We thank Yufan Liang for assistance with chiral HPLC, and
Hans Renata, Christopher Prier, and Sheel Dodani for helpful
discussions. This work was supported by the Department of the
Navy, Oﬃce of Naval Research (Grant N00014-11-0205), and
the Jacobs Institute for Molecular Engineering for Medicine at
Caltech. C.C.F and R.K.Z. are supported by NSF graduate
research fellowships. T.K.H and J.A.M. are supported by
Table 3. Substrate Scope of Aziridination with P-I263F-
A328V-L437V Showing Productivity and Selectivity for Each
Producta
aReactions were carried out with whole cells expressing P-I263F-
A328V-L437V under anaerobic conditions, with 2.5 mM tosyl azide
and 7.5 mM oleﬁn. b% ee determined as (S − R)/(S + R). Absolute
conﬁgurations were assigned based on analogy to 6. rac = racemic.
ACS Central Science Research Article
DOI: 10.1021/acscentsci.5b00056
ACS Cent. Sci. 2015, 1, 89−93
92
Ruth L. Kirschstein National Research Service Awards
(F32GM108143) (F32GM101792).
■ REFERENCES
(1) (a) Bornscheuer, U. T.; et al. Engineering the third wave of
biocatalysis. Nature 2012, 485, 185−194. (b) Savile, C. K.; et al.
Biocatalytic asymmetric synthesis of chiral amines from ketones
applied to Sitagliptin manufacture. Science 2010, 329, 305−309.
(2) (a) Bornscheuer, U. T.; Kazlauskas, R. J. Catalytic promiscuity in
biocatalysis: using old enzymes to form new bonds and follow new
pathways. Angew. Chem., Int. Ed. 2004, 43, 6032−6040. (b) McIntosh,
J. A.; Farwell, C. C.; Arnold, F. H. Expanding P450 catalytic reaction
space through evolution and engineering. Curr. Opin. Chem. Biol. 2014,
19, 126−134. (c) Renata, H.; Wang, Z. J.; Arnold, F. H. Expanding the
enzyme universe: accessing non-natural reactions by mechanism-
guided directed evolution. Angew. Chem., Int. Ed. 2015, 54, 3351−
3367. (d) Toscano, M. D.; Woycechowsky, K. J.; Hilvert, D.
Minimalist active-site redesign: teaching old enzymes new tricks.
Angew. Chem., Int. Ed. 2007, 46, 3212−3236.
(3) (a) Wang, Z. J.; et al. Improved cyclopropanation activity of
histidine-ligated cytochrome P450 enables the enantioselective formal
synthesis of levomilnacipran. Angew. Chem., Int. Ed. 2014, 53, 6810−
6813. (b) Seitz, M.; et al. Synthesis of heterocyclic terpenoids by
promiscuous squalene-hopene cyclases. ChemBioChem 2013, 14, 436−
439. (c) Hammer, S. C.; et al. Stereoselective friedel-crafts alkylation
catalyzed by squalene hopene cyclases. Tetrahedron 2012, 68, 7624−
7629.
(4) McIntosh, J. A.; et al. Enantioselective intramolecular C−H
amination catalyzed by engineered cytochrome P450 enzymes in vitro
and in vivo. Angew. Chem., Int. Ed. 2013, 52, 9309−9312.
(5) (a) Singh, R.; Bordeaux, M.; Fasan, R. P450-catalyzed
intramolecular sp3 C−H amination with arylsulfonyl azide substrates.
ACS Catal. 2014, 4, 546−552. (b) Singh, R.; Kolev, J. N.; Sutera, P. A.;
Fasan, R. Enzymatic C(sp3)-H amination: P450-catalyzed conversion
of carbonazidates into oxazolidinones. ACS Catal. 2015, 5, 1685−
1691.
(6) Farwell, C. C.; et al. Enantioselective imidation of sulfides via
enzyme-catalyzed intermolecular nitrogen-atom transfer. J. Am. Chem.
Soc. 2014, 136, 8766−8771.
(7) Che, C.-M.; Lo, V. K.-Y.; Zhou, C.-Y.; Huang, J.-S. Selective
functionalisation of saturated C−H bonds with metalloporphyrin
catalysts. Chem. Soc. Rev. 2011, 40, 1950−1975.
(8) (a) Degennaro, L.; Trinchera, P.; Luisi, R. Recent advances in the
stereoselective synthesis of aziridines. Chem. Rev. 2014, 114, 7881−
7929. (b) Yudin, A. K. Aziridines and Epoxides in Organic Synthesis;
Wiley-VCH Verlag GmbH: 2006.
(9) (a) Mansuy, D.; Mahy, J. P.; Dureault, A.; Bedi, G.; Battioni, P.
Iron- and manganese-porphyrin catalysed aziridination of alkenes by
tosyl- and acyl-iminoiodobenzene. J. Chem. Soc., Chem. Commun. 1984,
17, 1161−1163. (b) Vyas, R.; Goa, G.-Y.; Harden, J. D.; Zhang, X. P.
Iron(III) porphyrin catalyzed aziridination of alkenes with bromamine-
T as nitrene source. Org. Lett. 2004, 6, 1907−1910.
(10) (a) Gao, G.-Y.; Jones, J. E.; Vyas, R.; Harden, J. D.; Zhang, X. P.
Cobalt-catalyzed aziridination with diphenylphosphoryl azide (DPPA):
direct synthesis of N-phosphorus-substituded aziridines from alkenes.
J. Org. Chem. 2006, 71, 6655−6658. (b) Ruppel, J. V.; Jones, J. E.;
Huff, C. A.; Kamble, R. M.; Chen, Y.; Zhang, X. P. A highly effective
cobalt catalyst for olefin aziridination with azides: hydrogen bonding
guided catalyst design. Org. Lett. 2008, 10, 1995−1998. (c) Jin, L. M.;
Xu, X.; Lu, H.; Cui, X.; Wojtas, L.; Zhang, X. P. Effective synthesis of
chiral N-fluoroaryl aziridines through enantioselective aziridnation of
alkenes with fluoroaryl azides. Angew. Chem., Int. Ed. 2013, 52, 5309−
5313. (d) Lui, Y.; Che, C. M. [FeIII(F20-tpp)Cl] is an effective
catalyst for nitrene transfer reactions and amination of saturated
hydrocarbons with sulfonyl and aryl azides as nitrogen source under
thermal and microwave-assisted conditions. Chem.Eur. J. 2010, 16,
10494−10501.
(11) (a) Dodani, S. C.; et al. Structural, functional, and spectroscopic
characterization of the substrate scope of the novel nitrating
cytochrome P450 TxtE. ChemBioChem 2014, 15, 2259−2267.
(b) Barry, S. M.; et al. Cytochrome P450-catalyzed L-tryptophan
nitration in thaxtomin phytotoxin biosynthesis. Nat. Chem. Biol. 2012,
8, 814−816.
(12) Thibodeaux, C. J.; Chang, W.-c.; Liu, H.-w. Enzymatic chemistry
of cyclopropane, epoxide, and aziridine biosynthesis. Chem. Rev. 2012,
112, 1681−1709.
(13) (a) Hyster, T. K.; et al. Enzyme-controlled nitrogen-atom
transfer enables regiodivergent C−H amination. J. Am. Chem. Soc.
2014, 136, 15505−15508. (b) Coelho, P. S.; et al. A serine-substituted
P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat.
Chem. Biol. 2013, 9, 485−487.
(14) (a) Yosca, T. H.; et al. Iron(IV)hydroxide pKa and the role of
thiolate ligation in C−H bond activation by cytochrome P450. Science
2013, 342, 825−829. (b) Sono, M.; Andersson, L. A.; Dawson, J. H.
Sulfur donor ligand binding to ferric cytochrome P-450-cam and
myoglobin. Ultraviolet-visible absorption, magnetic circular dichroism,
and electron paramagnetic resonance spectroscopic investigation of
the complexes. J. Biol. Chem. 1982, 257, 8308−8320.
(15) Perera, R.; et al. Molecular basis for the inability of an oxygen
atom donor ligand to replace the natural sulfur donor heme axial
ligand in cytochrome P450 catalysis. Spectroscopic characterization of
the Cys436Ser CYP2B4 mutant. Arch. Biochem. Biophys. 2011, 507,
119−125.
(16) Heel, T.; et al. Non-natural olefin cyclopropanation catalyzed by
diverse cytochrome P450s and other hemoproteins. ChemBioChem
2014, 15, 2556−2562.
(17) (a) Ando, T.; et al. Iodine-catalyzed aziridination of alkenes
using chloramine-T as a nitrogen source. Tetrahedron 1998, 54,
13485−13494. (b) Kiyokawa, K.; Kosaka, T.; Minakata, S. Metal-free
aziridination of styrene derivatives with iminoiodinane catalyzed by a
combination of iodine and ammonium iodide. Org. Lett. 2013, 15,
4858−4861.
(18) (a) Sevrioukova, I. F.; et al. Structure of cytochrome P450-redox
partner electron-transfer complex. Proc. Natl. Acad. Sci. U.S.A. 1999,
96, 1863−1868. (b) Ost, T. W.; et al. Phenylalanine 393 exerts
thermodynamic control over the heme of flavocytochrome P450 BM3.
Biochemistry 2001, 40, 13421−13429. (c) Roitel, O.; Scrutton, N. S.;
Munro, A. W. Electron transfer in flavocytochrome P450 BM3:
kinetics of flavin reduction and oxidation, the role of cysteine 999, and
relationships with mammalian cytochrome P450 reductase. Biochem-
istry 2003, 42, 10809−10821.
ACS Central Science Research Article
DOI: 10.1021/acscentsci.5b00056
ACS Cent. Sci. 2015, 1, 89−93
93
